1.Zhang Y, Dong X, Guo X, Li C, Fan Y, Liu P, Yuan D, Ma X, Wang J, Zheng J, Li H,Gao P*. LncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancer.Mol Cancer. 2023 Mar 1;22(1):41.(SCI收录,IF=41.44)
2.Zhang G, Gao Z, Guo X, Ma R, Wang X, Zhou P, Li C, Tang Z, Zhao R,Gao P*. CAP2 promotes gastric cancer metastasis by mediating the interaction between tumor cells and tumor-associated macrophages.J Clin Invest. 2023 Sep 14:e166224. doi: 10.1172/JCI166224. Epub ahead of print.(SCI收录,IF=15.9)
3.Liu HT, Zou YX, Zhu WJ, Sen-Liu, Zhang GH, Ma RR, Guo XY,Gao P*.lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus.Cell Death Differ. 2022 Mar;29(3):627-641.(SCI收录,IF=15.83)
4.Liu HT, Gao ZX, Li F, Guo XY, Li CL, Zhang H, Zhao RN, Liu Y, Shi DB, Zhu WJ, Gao P. LncRNA LY6E-DT and its encoded metastatic-related protein play oncogenic roles via different pathways and promote breast cancer progression.Cell Death Differ. 2024 Feb;31(2):188-202(SCI收录,IF=15.83)
5.Zhu W, Chen X, Guo X, Liu H, Ma R, Wang Y, Liang Y, Sun Y, Wang M, Zhao R,Gao P*. Low Glucose-Induced Overexpression of HOXC-AS3 Promotes Metabolic Reprogramming of Breast Cancer.Cancer Res. 2022 Mar 1;82(5):805-818(SCI收录,IF=12.72)